Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
about
Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease.Advances in bioanalytical LC-MS using the Orbitrap™ mass analyzer.Transdermal donepezil on the treatment of Alzheimer's disease.In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter.
P2860
Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Determination of therapeutics ...... e for doping control purposes.
@ast
Determination of therapeutics ...... e for doping control purposes.
@en
Determination of therapeutics ...... e for doping control purposes.
@nl
type
label
Determination of therapeutics ...... e for doping control purposes.
@ast
Determination of therapeutics ...... e for doping control purposes.
@en
Determination of therapeutics ...... e for doping control purposes.
@nl
prefLabel
Determination of therapeutics ...... e for doping control purposes.
@ast
Determination of therapeutics ...... e for doping control purposes.
@en
Determination of therapeutics ...... e for doping control purposes.
@nl
P356
P1476
Determination of therapeutics ...... e for doping control purposes.
@en
P2093
Frauke Wilkens
Hans Geyer
P2860
P304
P356
10.1002/RCM.2758
P577
2006-01-01T00:00:00Z